A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.

Introduced on 4/16/26

No bill text yet

Legislation is often filed as a placeholder with no text. Check back later.

Sponsors

0
1
R
Democratic CaucusRepublican Caucus